ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993